Outset pauses shipments of dialysis accessory after FDA warning letter, denting sales outlook
Dive Brief: Outset Medical has paused distribution of an accessory for its Tablo Hemodialysis System in response to a warning letter, the company said in
Dive Brief: Outset Medical has paused distribution of an accessory for its Tablo Hemodialysis System in response to a warning letter, the company said in
Psychedelic science is in its infancy stage, so there is a lot that is still unknown. One of these unknowns is the safety and efficacy
Cybin Inc. (NYSE American:CYBN / NEO:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that
Mind Medicine Inc. (NASDAQ: MNMD / NEO: MMED), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its
Cybin Inc. (NYSE American:CYBN / NEO:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased
Mind Medicine (MindMed) Inc (NASDAQ: MNMD / NEO: MMED), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that
FSD Pharma Inc. (NASDAQ:HUGE / CSE:HUGE / FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment